Techniclone International Corp.
- Share via
The company said Thursday that a “major shareholder” agreed to buy 1 million of its shares for $1,500,000.
In a press release, the Tustin company said it will use proceeds from the sale to complete the necessary steps to submit its Food and Drug Administration application for permission to conduct Phase 3 clinical trials with its LYM-1 therapeutic antibody.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
